argenx NV ADR (ARGX) — the earnings record
Computed on 2026-09-18 from the vendor's per-print history with the Print Record's method — no desk-written read yet. An investment research diary, not advice.
The record at a glance
Reactions across the covered prints span -6.9% to +6.5% — the beat column and the reaction column frequently disagree, which is the whole reason the record scores them separately. The street carries est EPS $8.37 · est revenue ~$3.35B into the next print.
Print by print
| Date | EPS | Revenue | |
|---|---|---|---|
| Jul 26 | 2026-07-23 | ✓ beat | ✓ beat |
| May 26 | 2026-05-07 | ✓ beat | ✓ beat |
| Oct 25 | 2025-10-30 | ✓ beat | ✗ miss |
| May 25 | 2025-05-08 | ✓ beat | ✗ miss |
| Oct 24 | 2024-10-31 | ✓ beat | ✗ miss |
| May 24 | 2024-05-09 | ✗ miss | ✗ miss |
| Oct 23 | 2023-10-31 | ✓ beat | ✓ beat |
| May 23 | 2023-05-04 | ✓ beat | ✓ beat |
| Jul 22 | 2022-07-28 | ✓ beat | ✓ beat |
| Mar 22 | 2022-03-21 | ✓ beat | ✓ beat |
Report-day close to the close three sessions later on adjusted closes, ±3% bands — the same method as every hand-written card; the Print Record method explains the bands. No reaction chart, metric line or behavior read exists for ARGX yet.
FAQ · from the current data · as of 2026-09-18
Quick answers
How often does argenx NV ADR beat earnings estimates?
Across the last 10 covered prints (as of the 2026-09-18 card), argenx NV ADR beat EPS estimates 9 of 10 times and revenue estimates 6 of 10 times, with 6 double beats.
How does ARGX stock react to earnings?
Measured close-of-print-day to the close three sessions later: 3 of the last 10 prints resolved up (beyond +3%), 3 flat, 4 down — reactions spanning -6.9% to +6.5%. Beat-or-miss and reaction are scored separately because they frequently disagree.
What was ARGX's biggest earnings reaction?
-6.9% over the three sessions after the May 24 print (2024-05-09).
When does argenx NV ADR report earnings next?
2027-03-04 (2027-03-04 · est EPS $8.37 · est revenue ~$3.35B). This record is computed from the vendor's per-print history with the Print Record's method; a desk-written card for ARGX does not exist yet. An investment research diary, not advice.
Mentioned on Closelook
Where ARGX appears in the diary — 1 piece, newest first. Every link is our own writing.
Go deeper
Dailies
- A chart pick published at 95.10 this morning trades 107.92 by midday — Robinhood's triangle breaks up through the 100 shelf — as the CAC snaps seven straight red sessions and Bitcoin adds another six percent above 77,000
Barchart's large-cap 52-week new-high list, as of 11:59 CDT, carries 31 names and reads like the ex-tech thesis printed as breadth: twelve are health care, biotech or pharma — ARGX, BDX, BIO, CORT, HALO, MRK, REGN, RVTY, THC, TVTX, TXG…
Related in the Closelook universe
then Biotechnology. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- BION.SW BB Biotech AGindustry
- ARGX.BR Argen-Xindustry
- ONC BeiGene, Ltd.industry
- REGN Regeneron Pharmaceuticals Incindustry
- UCB.BR UCB SAindustry
- ZEAL.CO Zealand Pharma A/Sindustry
- MRNA Moderna Incindustry
- TWST Twist Bioscience Corpindustry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- SMMT Summit Therapeutics PLCindustry
- HALO Halozyme Therapeutics Incindustry
- TLX.AU TELIX Pharmaceuticals Ltdindustry
- SRPT Sarepta Therapeutics Incindustry
- GMAB Genmab ASindustry
- IBRX Immunitybio Incindustry
- CRSP Crispr Therapeutics AGindustry
- EXEL Exelixis Incindustry
- TGTX TG Therapeutics Incindustry
- MRVI Maravai Lifesciences Holdings Incindustry
- INCY Incyte Corporationindustry